This article has been updated from an earlier version to include details from spokesman.
NEW YORK, Sept. 10 (GenomeWeb News) - Frank Laukien, president and CEO of Bruker BioSciences, is expected to provide details of his company's recently announced reorganization at next week's Bear Stearns healthcare conference, according to a company spokesman.
Earlier today, Bruker said it has laid off around 60 employees worldwide as it tries to rein in "creeping" expenses. The company also said it has "reorganized various production, research and development, sales and administration functions" to help save additional money. The move is expected to save the company $6 million in the fourth quarter of this year, and for the whole of 2005.
Bruker "had some bottom-line set-backs and expense creep recently, which we intend to counter with this additional cost-cutting program that has affected all of our operating companies and geographies," Laukien said in a statement.
Laukien is scheduled to speak at Eastern Standard Time on Monday, Sept. 13. The presentation will be webcast on Bruker's website.